Release Date: 28/04/17 08:36 Summary: Pacific Consortium Revised Indicative Proposal not Superior Price Sensitive: Yes Download Document 340.03KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market